ATEC (Alphatec Holdings, Inc.) Stock Financials & Earnings | Market Cap Arena

ATEC (Alphatec Holdings, Inc.) Stock Financials & Earnings | Market Cap Arena

ATECAlphatec Holdings, Inc.

Mkt Cap$2B

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$764M

Net Income (TTM)-$143M

EPS (TTM)-$0.96

Free Cash Flow (TTM)$3M

Gross Margin67.1%

Op. Margin-10.3%

Net Margin-18.8%

FCF Margin0.4%

P/S Ratio (TTM)2.5x

P/E Ratio (TTM)—

YoY Rev Growth+25.0%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$109M	$70M	-$37M
Q2 23	$117M	$65M	-$50M
Q3 23	$118M	$80M	-$38M
Q4 23	$138M	$95M	-$45M
Q1 24	$138M	$97M	-$43M
Q2 24	$146M	$103M	-$35M
Q3 24	$151M	$103M	-$34M
Q4 24	$177M	$122M	-$24M
Q1 25	$169M	$116M	-$44M
Q2 25	$186M	$129M	-$13M
Q3 25	$197M	$137M	-$16M
Q4 25	$213M	$130M	-$5M

Valuation

Quarter	P/S	P/E
Q1 23	4.8x	—
Q2 23	4.5x	—
Q3 23	4.2x	—
Q4 23	3.9x	—
Q1 24	3.7x	—
Q2 24	3.5x	—
Q3 24	3.3x	—
Q4 24	3.1x	—
Q1 25	2.9x	—
Q2 25	2.8x	—
Q3 25	2.6x	—
Q4 25	2.5x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$18M	-$35M
Q2 23	-$18M	-$38M
Q3 23	-$17M	-$39M
Q4 23	-$25M	-$53M
Q1 24	-$38M	-$72M
Q2 24	-$11M	-$47M
Q3 24	-$5M	-$25M
Q4 24	$11M	$7M
Q1 25	-$5M	-$15M
Q2 25	$16M	$3M
Q3 25	$14M	$5M
Q4 25	$21M	$10M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$17M
Q2 23	$21M
Q3 23	$21M
Q4 23	$28M
Q1 24	$34M
Q2 24	$36M
Q3 24	$20M
Q4 24	$4M
Q1 25	$10M
Q2 25	$12M
Q3 25	$9M
Q4 25	$11M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+53.8%	+41.6%
Q2 23	+38.9%	+46.1%
Q3 23	+31.6%	+25.5%
Q4 23	+30.2%	+29.7%
Q1 24	+26.9%	+24.5%
Q2 24	+24.5%	+8.5%
Q3 24	+27.4%	+17.8%
Q4 24	+28.1%	+9.7%
Q1 25	+22.2%	+17.4%
Q2 25	+27.5%	+9.8%
Q3 25	+30.4%	+15.2%
Q4 25	+20.4%	+8.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$16M	15.1%
Q2 23	$24M	20.7%
Q3 23	$20M	17.0%
Q4 23	$21M	14.9%
Q1 24	$17M	12.5%
Q2 24	$17M	11.7%
Q3 24	$17M	11.6%
Q4 24	$22M	12.2%
Q1 25	$22M	13.2%
Q2 25	$16M	8.4%
Q3 25	$16M	8.3%
Q4 25	$19M	9.1%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$13M	$91M
Q2 23	$15M	$87M
Q3 23	$20M	$91M
Q4 23	$22M	$104M
Q1 24	$18M	$114M
Q2 24	$19M	$113M
Q3 24	$20M	$109M
Q4 24	$23M	$115M
Q1 25	$17M	$127M
Q2 25	$18M	$119M
Q3 25	$19M	$124M
Q4 25	$23M	$113M

Revenue Segments

Quarter	Products And Services
Q1 23	$109M
Q2 23	$117M
Q3 23	$118M
Q4 23	$138M
Q1 24	$138M
Q2 24	$146M
Q3 24	$151M
Q4 24	$177M
Q1 25	$169M
Q2 25	$186M
Q3 25	$197M
Q4 25	$213M

Revenue by Geography

Quarter	Non-US	United States
Q1 23	$9M	$100M
Q2 23	$9M	$108M
Q3 23	$8M	$110M
Q4 23	$10M	$128M
Q1 24	$9M	$130M
Q2 24	$9M	$136M
Q3 24	$9M	$142M
Q4 24	$14M	$163M
Q1 25	$10M	$159M
Q2 25	$11M	$175M
Q3 25	$12M	$184M
Q4 25	$15M	$198M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$117M	$0	$117M
Q2 23	$101M	$0	$101M
Q3 23	$123M	$0	$123M
Q4 23	$221M	$0	$221M
Q1 24	$144M	$0	$144M
Q2 24	$100M	$0	$100M
Q3 24	$81M	$0	$81M
Q4 24	$139M	$0	$139M
Q1 25	$153M	$0	$153M
Q2 25	$157M	$0	$157M
Q3 25	$156M	$0	$156M
Q4 25	$161M	$0	$161M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	110M	+3.7%
Q2 23	119M	+8.2%
Q3 23	122M	+3.2%
Q4 23	134M	+9.2%
Q1 24	141M	+5.4%
Q2 24	143M	+1.2%
Q3 24	143M	+0.6%
Q4 24	143M	-0.4%
Q1 25	147M	+2.6%
Q2 25	150M	+2.2%
Q3 25	151M	+1.0%
Q4 25	150M	-0.9%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$460K	450
FY 15	$431K	430
FY 16	$742K	162
FY 17	$737K	138
FY 18	$470K	195
FY 19	$500K	227
FY 20	$489K	296
FY 21	$434K	561
FY 22	$498K	705
FY 23	$575K	839
FY 24	$705K	867
FY 25	$837K	913